Clinical Trial Update: ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of ABT-335 (choline fenofibrate) for dyslipidemia has completed with results posted in 2011. The study evaluated reverse cholesterol tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• ABT-335 (Choline Fenofibrate) (Choline fenofibrate)

Snippet

Sponsor: Radiant Research | Conditions: Dyslipidemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-04-20